Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboxane synthesis and action within the kidney.

G Remuzzi, G A FitzGerald, C Patrono

    Kidney International
    |June 1, 1992
    PubMed
    Summary

    Prostaglandin H2 (PGH2) and Thromboxane A2 (TxA2) play roles in smooth muscle contraction and platelet aggregation. Targeting renal TxA2 biosynthesis may offer new treatments for kidney diseases.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    RENEB Inter-Laboratory Comparison 2021: Inter-Assay Comparison of Eight Dosimetry Assays.

    Radiation research·2023
    Same author

    RENEB Inter-Laboratory Comparison 2021: The Cytokinesis-Block Micronucleus Assay.

    Radiation research·2023
    Same author

    RENEB Inter-Laboratory Comparison 2021: The Dicentric Chromosome Assay.

    Radiation research·2023
    Same author

    A NOVEL BIOLOGICAL DOSIMETRY ASSAY AS A POTENTIAL TOOL FOR TRIAGE DOSE ASSESSMENT IN CASE OF LARGE-SCALE RADIOLOGICAL EMERGENCY.

    Radiation protection dosimetry·2019
    Same author

    Coxibs, Traditional NSAIDs, and Cardiovascular Safety Post-PRECISION: What We Thought We Knew Then and What We Think We Know Now.

    Clinical pharmacology and therapeutics·2017
    Same author

    In Silico Modeling of the Antiplatelet Pharmacodynamics of Low-dose Aspirin in Health and Disease.

    Clinical pharmacology and therapeutics·2017

    Area of Science:

    • Biochemistry
    • Physiology
    • Pharmacology

    Background:

    • Prostaglandin H2 (PGH2) and Thromboxane A2 (TxA2) mediate cellular functions through specific receptor isoforms.
    • These eicosanoids activate phospholipase C, leading to platelet aggregation and smooth muscle contraction in vascular, bronchial, and glomerular mesangial cells.

    Discussion:

    • While PGH2 and TxA2 have minimal impact on normal renal function, their biosynthesis is elevated in various kidney disease models and clinical conditions.
    • In vitro studies on renal tissues and in vivo pharmacological interventions targeting TxA2 synthesis and action indicate therapeutic potential.

    Key Insights:

    • PGH2/TxA2 signaling is implicated in platelet aggregation and smooth muscle contraction via phospholipase C activation.
    • Increased renal TxA2 biosynthesis is a feature of several kidney diseases.
    • Pharmacological modulation of TxA2 pathways shows promise for treating kidney disorders.

    Outlook:

    • Further research into the role of TxA2 in renal pathophysiology could lead to novel therapeutic strategies.
    • Interventions targeting TxA2 synthesis or action may offer new avenues for managing human kidney diseases.

    Related Experiment Videos